Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
17
PharmaCompass offers a list of Bismuth Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bismuth Citrate manufacturer or Bismuth Citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bismuth Citrate manufacturer or Bismuth Citrate supplier.
PharmaCompass also assists you with knowing the Bismuth Citrate API Price utilized in the formulation of products. Bismuth Citrate API Price is not always fixed or binding as the Bismuth Citrate Price is obtained through a variety of data sources. The Bismuth Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bismuth Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bismuth Citrate, including repackagers and relabelers. The FDA regulates Bismuth Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bismuth Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bismuth Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bismuth Citrate supplier is an individual or a company that provides Bismuth Citrate active pharmaceutical ingredient (API) or Bismuth Citrate finished formulations upon request. The Bismuth Citrate suppliers may include Bismuth Citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Bismuth Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bismuth Citrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Bismuth Citrate active pharmaceutical ingredient (API) in detail. Different forms of Bismuth Citrate DMFs exist exist since differing nations have different regulations, such as Bismuth Citrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bismuth Citrate DMF submitted to regulatory agencies in the US is known as a USDMF. Bismuth Citrate USDMF includes data on Bismuth Citrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bismuth Citrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bismuth Citrate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bismuth Citrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bismuth Citrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bismuth Citrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bismuth Citrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bismuth Citrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bismuth Citrate suppliers with NDC on PharmaCompass.
Bismuth Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bismuth Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bismuth Citrate GMP manufacturer or Bismuth Citrate GMP API supplier for your needs.
A Bismuth Citrate CoA (Certificate of Analysis) is a formal document that attests to Bismuth Citrate's compliance with Bismuth Citrate specifications and serves as a tool for batch-level quality control.
Bismuth Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Bismuth Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bismuth Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Bismuth Citrate EP), Bismuth Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bismuth Citrate USP).
